Quick Answer
Yes, multiple sclerosis can qualify for the Disability Tax Credit Canada in 2026, most often under walking or mental functions. Both relapsing-remitting and progressive MS may qualify when fatigue, mobility, or cognitive symptoms markedly restrict daily activities at least 90% of the time. The cumulative effect rule often applies to MS claims.
How MS Can Qualify for the DTC
MS affects different people differently. CRA does not approve or deny based on diagnosis alone. The question is always: do your specific MS symptoms markedly restrict a basic activity of daily living 90% or more of the time?
Common qualifying categories for MS include:
- Walking: gait impairment, foot drop, spasticity, balance issues, or fatigue that severely limits walking distance
- Dressing: fine motor impairment, spasticity, or fatigue preventing independent dressing
- Mental functions: MS-related cognitive impairment ("MS fog"), memory, concentration, and executive function problems
- Vision: optic neuritis causing lasting vision impairment
- Bladder/bowel: severe neurogenic bladder or bowel dysfunction taking inordinate time to manage
- Cumulative effect: multiple moderate restrictions combining to equal a marked restriction
Relapsing-Remitting MS and the 90% Rule
RRMS presents a unique challenge because symptoms fluctuate. CRA's 90% rule means restriction must exist most of the time. For RRMS:
- Frequent or prolonged relapses that cumulatively exceed 90% of the year can qualify
- Persistent inter-relapse impairment (fatigue, cognitive issues, heat sensitivity) that affects daily function can count toward the 90%
- Accumulated neurological damage that causes baseline impairment between relapses is particularly important to document
Progressive MS (primary progressive, secondary progressive) typically has an easier path to qualification because restriction is more consistent and ongoing.
MS Fatigue as a DTC Factor
MS fatigue is often overlooked but can be one of the most disabling aspects of the condition. If MS fatigue is severe enough that it restricts walking, dressing, or other activities 90% of the time, it can support a DTC claim. Your neurologist should document the severity and functional impact of MS fatigue specifically, as generic fatigue documentation is often insufficient.
Key Documentation for MS DTC
- Neurologist report detailing current functional limitations (not just MRI findings or diagnosis)
- Expanded Disability Status Scale (EDSS) score from your neurologist, scores of 4.0 and above typically indicate significant mobility restriction
- Physiotherapy assessment of walking capacity and balance
- Occupational therapy report on activities of daily living
- Neuropsychological testing if cognitive impairment is a primary symptom
- Documentation of MS fatigue severity and functional impact
- Records of disease-modifying therapy and its effects on function
2026 DTC Amounts for MS
If approved: federal credit $1,481 per year. Combined with provincial: $2,080 to $3,741 per year. Retroactive claims for years of qualifying MS disability over 10 years can total $14,000 to $37,000 or more.
Real multiple sclerosis Filing Scenario
The following example is illustrative. It describes a typical filing flow and does not predict any individual outcome.
A Toronto-area resident with relapsing-remitting multiple sclerosis met with her neurologist to complete Part B. The neurologist documented walking restriction (limited endurance, frequent rest required) and cognitive fatigue affecting mental functions, both anchored to MRI findings and EDSS scoring. Part B addressed section 6 explicitly, certifying that the cumulative effect takes more than 14 hours per week of extra support and time across both restrictions. The Notice of Determination arrived 12 weeks after submission, approving the DTC retroactive to 2022.
Documentation That Works for multiple sclerosis Part B
What worked in this Part B: cumulative-effect attestation combining walking and mental functions, plus objective neurological findings (EDSS score, MRI). MS claims succeed when both motor and cognitive aspects are documented under section 6, rather than relying on a single category. See our cumulative effects rule guide for the technical framework CRA reviewers apply, and our DTC denied appeal guide if a previous application was rejected.
Frequently Asked Questions
CRA assesses function "with appropriate therapy," which includes your disease-modifying medications. If your MS medications allow near-normal function, you may not currently qualify. However, if significant impairment remains despite optimal treatment, the claim can still succeed. Many people with MS who take medication still experience fatigue, cognitive issues, or mobility limitations that meet the threshold.
If you are currently asymptomatic or minimally impaired, you likely would not qualify at this time. DTC eligibility is based on functional impairment, not diagnosis alone. However, you should consider applying as your condition progresses, and keep in mind that you can apply retroactively later for years when your impairment was significant.
Your neurologist is the most appropriate certifier for MS, as they have documented your diagnosis, monitoring, and functional status over time. A general practitioner who manages your MS care can also certify. The certifier should be able to speak specifically to your functional limitations, not just your disease status or MRI findings.
Yes. If your MS was severe enough to qualify in prior years, you can apply retroactively for up to 10 years. Your neurologist can certify the start date of your qualifying impairment based on clinical records and EDSS scores from prior visits. This is particularly valuable for progressive MS patients who have had years of restriction before applying.